Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Mammoth Labs operated as a single-category brand with Concentrates at 100.0% mix, posting year-over-year sales growth of 867.7% alongside a month-over-month decline of 44.1%. Average price fell 66.0% YoY to $13.73 while category share stayed concentrated at 100.0%, indicating volume expansion YoY paired with a short-term pullback MoM; the pattern implies a tactical reset after aggressive price-led reentry rather than a broad portfolio shift.
With all sales in Concentrates and no reported rank in Nevada Concentrates, the 867.7% YoY surge paired with a 44.1% MoM drop and a 66.0% YoY price compression suggests Mammoth Labs is trading margin for visibility while absorbing volatility typical of a re-launch curve. The mix locked at 100.0% and the MoM contraction imply overexposure to a single demand cycle; strategically, this positioning concentrates risk and signals the need to translate July 2026 price elasticity into sustained rank traction in Nevada rather than continuing to rely on discount-driven volume spikes.
Competitive Landscape
Mammoth Labs sits at rank #37 in Nevada Concentrates for July 2026, sliding 9 positions from #28 in April 2026 and sitting 27 places below its peak at #10 in September 2024; while year-over-year rank is unavailable, the current #37 versus a top-5 cohort indicates a widening competitive gap. In contrast, Medizin holds #1 despite a 29.8% year-over-year sales decline and Alternative Medicine Association / AMA remains #2 with an 8.4% year-over-year sales increase, whereas Hippies surged from #32 to #3 alongside a 669.6% year-over-year sales jump; this mix of a #1 leader shrinking and a #3 riser accelerating implies Mammoth Labs’ downward rank trajectory reflects lost share to fast-climbing mid-tier entrants rather than only top-heavy pressure.

Notable Products
The steepest decline came from Citrus Breadsticks Live Resin Badder (2g) at -92.8% month over month while falling to a tie at rank 5, and the concurrent -41.6% slide for Apples and Bananas Live Resin Badder (0.05g) at rank 4 indicates sharp volatility at the low-volume end; this pattern implies inventory or SKU rationalization rather than broad demand erosion. Offsetting that, Pinesol Kush Live Resin Badder (2g) jumped 82.8% MoM to rank 2 while Gary Poppins Badder (1g) rose 50.8% to rank 3, suggesting consumer trade-up into larger or established formats even as Pinesol Kush Live Resin Badder (0.05g) at rank 1 declined 34.6%. With all top-5 positions concentrated in Concentrates and multiple 2g variants in the top tier, the mix points to Mammoth Labs leaning into higher-weight badder formats and pruning underperforming sub-sizes; the commercial direction is a pivot toward fewer, heavier SKUs to stabilize share and velocity.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







